BWBrainsWay Ltd. BWAY · NASDAQ
$11.98 -0.42% (-$0.05)
- Market cap
- $471.9M
- Enterprise value
- $416.6M
- P/E
- 49.4x
- Forward P/E
- 73.7x
- PEG
- 0.4x
- P/S
- 7.7x
- P/FCF
- 82.9x
- EV/EBITDA
- 34.2x
- ROIC
- 7.8%
- Bruto marža
- 75.3%
- Neto marža
- 15.7%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -4.5x
- Beta
- 0.15
- Free float
- 75.0%
O podjetju
BrainsWay Ltd. (BWAY) is a global company specializing in the development and production of non-invasive neurostimulation devices for the treatment of various neurological and psychiatric disorders. With innovative technologies and treatment approaches, including transcranial magnetic stimulation (TMS), BrainsWay Ltd. is a key player in the field of neuromodulation. The company focuses on providing effective and safe therapeutic options for patients with neurological and psychiatric disorders. BrainsWay Ltd. (BWAY) shares could be suitable for investors looking to invest in the innovative healthcare sector focused on neurological treatments.
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hadar Levy
Employees
129
Headquarters
Jerusalem
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke